Abbott Laboratories Shares Fall 13% YTD as Yield Reaches 2.2%
Abbott Laboratories shares have slid roughly 13% year-to-date despite the company sustaining a 54-year consecutive dividend growth streak. With a forward yield of about 2.2% versus the healthcare sector average of 1.6% and a 40.3% payout ratio, Abbott’s dividend appears well-supported by earnings.
1. Share Performance and Dividend Valuation
Abbott Laboratories shares have fallen roughly 13% year-to-date, creating a forward dividend yield near 2.2% that exceeds the healthcare sector average of 1.6%. The pullback has drawn attention to the company’s valuation relative to peers and its income appeal.
2. Dividend Growth Track Record
The company has raised dividends for 54 consecutive years, marking its 408th straight quarterly increase last year, when the payout rose by 6.8% to $0.63 per share. A payout ratio of about 40.3% indicates that earnings comfortably support continued distributions.
3. Segment Trends and Challenges
Abbott’s diversified portfolio includes medical devices, diagnostics, nutrition products and generics, which help stabilize revenue across economic cycles. Diagnostic sales have normalized following pandemic-related highs, while the nutrition segment faces volume headwinds from elevated manufacturing costs.